Assay method for cardiovascular disease
US6417006B1 · kind B1 · utility
1Cited by
3References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 5, 2000 |
| Grant date | Jul 9, 2002 |
| Priority date | — |
| Expiry date | Oct 5, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/145555
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
An assay method for detecting potential cardiovascular disease (CVD) in a vascularized subject by assessing the concentration of holo-transcobalamin II (holo-TCII) in a sample from the subject where abnormally low levels of holo-TCII are indicative of CVD or susceptibility to CVD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.